It looked like an over reaction this morning for a company that increased earnings, again.
Resmed is in a hot sector and targets a unique health problem.
Sleep Apnea still remains under-diagnosed which will provide RMD growth for years to come. Imo it could also be a acquisition target by an American health giant given its growth potential and cash flow.
A nice top up opportunity.
- Forums
- ASX - By Stock
- Ann: ResMed Announces Results for the Second Quarter of FY 2019
It looked like an over reaction this morning for a company that...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$38.15 |
Change
0.070(0.18%) |
Mkt cap ! $22.38B |
Open | High | Low | Value | Volume |
$38.10 | $38.22 | $37.91 | $30.20M | 792.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 956 | $38.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$38.15 | 2018 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13767 | 14.400 |
2 | 17668 | 14.390 |
3 | 20967 | 14.380 |
2 | 14124 | 14.370 |
4 | 21382 | 14.360 |
Price($) | Vol. | No. |
---|---|---|
14.430 | 22863 | 3 |
14.440 | 27216 | 4 |
14.450 | 46627 | 8 |
14.460 | 34563 | 7 |
14.470 | 22668 | 7 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |